Cargando…

Analysis of Key Factors of a SARS-CoV-2 Vaccination Program: A Mathematical Modeling Approach

The administration of vaccines against the coronavirus disease 2019 (COVID-19) started in early December of 2020. Currently, there are only a few approved vaccines, each with different efficacies and mechanisms of action. Moreover, vaccination programs in different regions may vary due to difference...

Descripción completa

Detalles Bibliográficos
Autores principales:	Martínez-Rodríguez, David, Gonzalez-Parra, Gilberto, Villanueva, Rafael-J.
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	MDPI 2021
Materias:	Article
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8824484/ https://www.ncbi.nlm.nih.gov/pubmed/35141702 http://dx.doi.org/10.3390/epidemiologia2020012

Ejemplares similares

Qualitative analysis of a mathematical model with presymptomatic individuals and two SARS-CoV-2 variants
por: González-Parra, Gilberto, et al.
Publicado: (2021)

Analysis of Delayed Vaccination Regimens: A Mathematical Modeling Approach
por: Gonzalez-Parra, Gilberto
Publicado: (2021)

Mathematical Modeling of Vaccines That Prevent SARS-CoV-2 Transmission
por: Swan, David A., et al.
Publicado: (2021)

Nonlinear Dynamics of the Introduction of a New SARS-CoV-2 Variant with Different Infectiousness
por: Gonzalez-Parra, Gilberto, et al.
Publicado: (2021)

Epidemiological Impact of SARS-CoV-2 Vaccination: Mathematical Modeling Analyses
por: Makhoul, Monia, et al.
Publicado: (2020)

SARS-CoV-2 Catalonia contact tracing program: evaluation of key performance indicators
por: Herrero, Mercè, et al.
Publicado: (2022)

Estimating immunity with mathematical models for SARS-CoV-2 after COVID-19 vaccination
por: Uwamino, Yoshifumi, et al.
Publicado: (2023)

Approaches and Challenges in SARS-CoV-2 Vaccine Development
por: Dagotto, Gabriel, et al.
Publicado: (2020)

A postmortem study of patients vaccinated for SARS-CoV-2 in Colombia
por: Chaves, Juan José, et al.
Publicado: (2023)

Vaccination against SARS-CoV-2 should be included in childhood vaccination programs
por: Petersen, Eskild, et al.
Publicado: (2021)

Emerging SARS-CoV-2 Variants and Impact in Global Vaccination Programs against SARS-CoV-2/COVID-19
por: Gómez, Carmen Elena, et al.
Publicado: (2021)

CRISPR-cas technology: A key approach for SARS-CoV-2 detection
por: Fang, Lijuan, et al.
Publicado: (2023)

A mathematical model reveals the influence of NPIs and vaccination on SARS-CoV-2 Omicron Variant
por: Wang, Bin-Guo, et al.
Publicado: (2022)

An Updated Review of SARS-CoV-2 Vaccines and the Importance of Effective Vaccination Programs in Pandemic Times
por: García-Montero, Cielo, et al.
Publicado: (2021)

Impact of Recommended Maternal Vaccination Programs on the Clinical Presentation of SARS-CoV-2 Infection: A Prospective Observational Study
por: de la Cruz Conty, Maria Luisa, et al.
Publicado: (2021)

SARS-CoV-2: To be or not to be vaccinated?
por: Beauchet, Olivier
Publicado: (2021)

Advanced Materials for SARS‐CoV‐2 Vaccines
por: Mabrouk, Moustafa T., et al.
Publicado: (2022)

Effectiveness of an Inactivated SARS-CoV-2 Vaccine in Chile
por: Jara, Alejandro, et al.
Publicado: (2021)

Glycosylation is key for enhancing drug recognition into spike glycoprotein of SARS-CoV-2
por: Ropón-Palacios, Georcki, et al.
Publicado: (2022)

Current status of therapeutic approaches and vaccines for SARS-CoV-2
por: Wahid, Braira, et al.
Publicado: (2021)

Approach to SARS-CoV-2 Vaccination in Patients With Multiple Sclerosis
por: Woopen, Christina, et al.
Publicado: (2021)

SARS CoV-2 vaccine AND rituximab, timing might be a key for a better vaccine response
por: Verhoeven, Frank, et al.
Publicado: (2021)

Evolution of SARS-CoV-2 Key Mutations in Vienna Detected by Large Scale Screening Program
por: Thannesberger, Jakob, et al.
Publicado: (2021)

Glycosylation is a key in SARS-CoV-2 infection
por: Reis, Celso A., et al.
Publicado: (2021)

Anti-SARS-CoV-2 IgA and IgG in human milk after vaccination is dependent on vaccine type and previous SARS-CoV-2 exposure: a longitudinal study
por: Selma-Royo, Marta, et al.
Publicado: (2022)

Stochastic epidemiological model: Simulations of the SARS-CoV-2 spreading in Mexico
por: López Vázquez, Pablo Carlos, et al.
Publicado: (2022)

An Exploration of Nanoparticle-Based Diagnostic Approaches for Coronaviruses: SARS-CoV-2, SARS-CoV and MERS-CoV
por: Al-Hindawi, Ahmed, et al.
Publicado: (2022)

Absence of SARS-CoV-2 Spike glycoprotein expression in placentas from individuals after mRNA SARS-CoV-2 vaccination
por: Santos, Andres, et al.
Publicado: (2022)

Consumption of Phenolic-Rich Food and Dietary Supplements as a Key Tool in SARS-CoV-19 Infection
por: Flores-Félix, José David, et al.
Publicado: (2021)

The Coronaviruses of Animals and Birds: Their Zoonosis, Vaccines, and Models for SARS-CoV and SARS-CoV2
por: Alluwaimi, Ahmed M., et al.
Publicado: (2020)

Risk of appendicitis after SARS-CoV-2 infection and SARS-CoV-2 vaccination
por: Ljung, Rickard, et al.
Publicado: (2022)

Vitiligo Repigmentation After SARS-CoV-2 Vaccine
por: Bustos-Macaya, Roberto, et al.
Publicado: (2023)

Determinants of access to the SARS-CoV-2 vaccine: a preliminary approach
por: de Oliveira, Brigitte Renata Bezerra, et al.
Publicado: (2021)

Development of vaccines for SARS-CoV-2
por: Ng, Wern Hann, et al.
Publicado: (2020)

Inactivated vaccine for SARS-CoV-2
por: Risson, Emma
Publicado: (2020)

Nanocarrier vaccines for SARS-CoV-2
por: Machhi, Jatin, et al.
Publicado: (2021)

SARS-CoV-2 Vaccines and the Skin()
por: Galván-Casas, C., et al.
Publicado: (2021)

SARS CoV2 vaccine and aphasia
por: sookaromdee, Pathum, et al.
Publicado: (2021)

SARS-CoV-2 Variants and Vaccines
por: Krause, Philip R., et al.
Publicado: (2021)

SARS-CoV-2 vaccine development
por: Mtewa, Andrew G., et al.
Publicado: (2022)

Cannot write session to /tmp/vufind_sessions/sess_kksg5uu2jpqk44pf68bm7l789k